For more than 85 years health care professionals have "referred to the
Red Book" for trustworthy guidance on pediatric infectious disease prevention, management, and control.
The new 33rd edition continues this tradition of distinction with the latest clinical guidance on the manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood infectious diseases.
Find the latest information about vaccines, emerging novel diseases, diagnostic modalities, and treatment recommendations from the combined expertise of the CDC, the FDA, the NIH, and hundreds of physician contributors.
Red Book guidance spans far beyond the pediatric practice to include family medicine, emergency medicine, public health, school health, and other medical specialties.
New in the 2024 Red Book- All chapters were assessed for relevance in the dynamic environment that is the practice of pediatric medicine today, and every chapter has been modified since the last edition.
- The chapter Discussing Vaccines With Patients and Parents has been significantly revised.
- Two new chapters on COVID-19 and Mpox have been added.
- Greatly expanded tables, figures, and algorithms enable quick access to essential information.
- The System-Based Treatment Table has been moved to the beginning of the book and has been reordered so that the grouped recommendations by body system are more easily and quickly accessed.
- Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout the Red Book.
- Reference to evidence-based policy recommendations have been updated throughout the Red Book.
- Appropriate chapters throughout the Red Book have been updated to be consistent with 2024 AAP and CDC vaccine recommendations, CDC recommendations for immunization of health care personnel, and drug recommendations from 2024 Nelson's Pediatric Antimicrobial Therapy.
- The Breastfeeding and Human Milk chapter was updated to align with information in the 2022 AAP policy statement on breastfeeding.
- The listing of Codes for Commonly Administered Pediatric Vaccines, Toxoids, and Immune Globulins has been expanded.
超過85年來，醫療專業人員一直參考《Red Book》，以獲得有關兒童傳染病預防、管理和控制的可靠指導。新版本的第33版延續了這一卓越傳統，提供了超過200種兒童傳染病的最新臨床指導，包括其表現、病因、流行病學、診斷和治療。
您可以找到來自CDC、FDA、NIH及數百位醫生貢獻者的最新疫苗資訊、新興疾病、診斷方式和治療建議。《Red Book》的指導範圍遠超過兒科實踐，還包括家庭醫學、急診醫學、公共衛生、學校健康及其他醫學專科。
2024年《Red Book》的新內容包括：
- 所有章節均已評估其在當今兒科醫學實踐中動態環境下的相關性，並自上版以來進行了修改。
- 章節《與患者及家長討論疫苗》已進行重大修訂。
- 新增兩個章節，分別為《COVID-19》和《Mpox》。
- 大幅擴展的表格、圖形和算法使得快速獲取重要資訊成為可能。
- 《基於系統的治療表》已移至書籍開頭，並重新排序，以便更輕鬆快速地訪問按身體系統分組的建議。
- 通過免疫接種、抗微生物預防和感染控制措施的標準化疾病預防方法已在整本《Red Book》中更新。
- 基於證據的政策建議的參考已在整本《Red Book》中更新。
- 整本《Red Book》中適當的章節已更新，以符合2024年AAP和CDC的疫苗建議、CDC對醫療人員免疫接種的建議，以及《2024 Nelson's Pediatric Antimicrobial Therapy》的藥物建議。
- 《母乳餵養與人乳》章節已更新，以符合2022年AAP關於母乳餵養的政策聲明中的資訊。
- 《常用兒童疫苗、類毒素和免疫球蛋白的代碼》列表已擴展。
David W. Kimberlin, MD, FAAP is the Editor of the 2021 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 and 2018 editions and was an Associate Editor of the 2012 and 2009 editions and served on the AAP Committee on Infectious Diseases from 2005- 2011. Dr. Kimberlin is the Sergio Stagno, MD. Endowed Chair in Infectious Diseases, Professor and Co-Division Director, Vice Chair for Clinical and Translational Research. His clinical and research interests include pediatric infectious diseases, antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome.
Dr. Ritu Banerjee is Professor in the Division of Pediatric Infectious Diseases at Vanderbilt University Medical Center. She is the Director of the Pediatric Antimicrobial Stewardship Program and Interim Director of Pediatric Infectious Diseases at Vanderbilt. She received her MD and Ph.D degrees from Washington University in St. Louis and then completed Pediatrics residency and Pediatric Infectious Disease fellowship at the University of California, San Francisco.She is a member of many national committees through the Pediatric Infectious Diseases Society, the American Academy of Pediatrics, the Infectious Diseases Society of America, and the Antibacterial Resistance Leadership Group. Dr. Banerjee conducts clinical research about antibiotic stewardship, implementation and outcomes of rapid blood culture diagnostics, and enhanced detection of carbapenem-resistant organisms.
Elizabeth D. Barnett, MD, FAAP is an Associate Editor of the 2021 Red Book and was a member of the Committee on Infectious Diseases from 2014 - 2020. Dr. Elizabeth Barnett is Professor of Pediatrics at Boston University School of Medicine and Chief, Section of Pediatric Infectious Diseases in the Department of Pediatrics at Boston Medical Center. She leads the Refugee Health Assessment Program and the Pediatric Travel Clinic. Her clinical and research interests include vaccines and vaccine safety, refugee and immigrant medicine, travel medicine, and general pediatric infectious diseases.
Ruth Lynfield, MD, FAAP is an Associate Editor of the 2021 Red Book and has been a member of the Committee on Infectious Diseases since 2015. Dr. Lynfield is the State Epidemiologist and Medical Director at the Minnesota Department of Health. She leads Minnesota's component of CDC's Emerging Infections Program Active Bacterial Core Surveillance System, influenza projects, and healthcare-associated infections projects. She is also Adjunct Professor of Medicine, and Epidemiology and Community Health at the University of Minnesota. Her clinical and research interests include pediatric infectious diseases, antimicrobial resistance and antimicrobial stewardship, emerging infections, prevention and control of infectious diseases, and outbreak response.
Mark Sawyer, MD, FAAP is an Associate Editor of the 2021 Red Book and served on the Committee on Infectious Diseases from 2013- 2019. Dr. Sawyer is an infectious disease specialist at Rady Children's Hospital and a professor of clinical pediatrics at UC San Diego. Additionally, Dr. Sawyer is vice chair for education in the UC San Diego Department of Pediatrics and the program director for the UC San Diego/Rady Children's Pediatric Residency Program and the medical director of the UC San Diego Immunization Partnership. His clinical and research interests include pediatric infectious diseases, medical education, training, and working with public health on the delivery of vaccines and national vaccine policy.
大衛·W·金伯林醫學博士（MD, FAAP）是2021年美國小兒科醫學會（AAP）傳染病委員會報告（紅皮書）的編輯。他曾擔任2015年和2018年版本的編輯，並在2012年和2009年版本中擔任副編輯，於2005年至2011年間擔任AAP傳染病委員會成員。金伯林醫生是塞爾吉奧·斯塔尼奧醫學博士（MD）傳染病講座教授、教授及共同部門主任，臨床與轉化研究副主任。他的臨床和研究興趣包括小兒傳染病、針對具有重大未滿足醫療需求的罕見疾病的抗病毒治療，包括新生兒單純皰疹病毒（HSV）感染、先天性巨細胞病毒（CMV）疾病、先天性茲卡病毒感染、新生兒及嬰幼兒流感感染，以及新生兒腸病毒敗血症綜合症。
瑞圖·班納吉醫生（Dr. Ritu Banerjee）是范德堡大學醫學中心小兒傳染病部的教授。她是小兒抗微生物管理計畫的主任，並擔任小兒傳染病的臨時主任。她在聖路易斯的華盛頓大學獲得醫學博士和博士學位，隨後在加州大學舊金山分校完成小兒科住院醫師訓練和小兒傳染病專科訓練。她是多個全國委員會的成員，包括小兒傳染病學會、美國小兒科醫學會、美國傳染病學會和抗菌耐藥領導小組。班納吉醫生進行有關抗生素管理、快速血培養診斷的實施與結果，以及增強檢測碳青霉烯耐藥生物的臨床研究。
伊莉莎白·D·巴內特醫生（MD, FAAP）是2021年紅皮書的副編輯，並於2014年至2020年期間擔任傳染病委員會成員。巴內特醫生是波士頓大學醫學院的小兒科教授，並擔任波士頓醫療中心小兒傳染病科的主任。她負責難民健康評估計畫和小兒旅行診所。她的臨床和研究興趣包括疫苗及疫苗安全、難民和移民醫學、旅行醫學以及一般小兒傳染病。
露絲·林菲爾德醫生（MD, FAAP）是2021年紅皮書的副編輯，自2015年以來一直是傳染病委員會的成員。林菲爾德醫生是明尼蘇達州衛生部的州流行病學家和醫療主任。她負責明尼蘇達州CDC新興感染計畫的主動細菌核心監測系統、流感專案和醫療相關感染專案。她同時也是明尼蘇達大學的醫學、流行病學和社區健康的兼任教授。她的臨床和研究興趣包括小兒傳染病、抗微生物耐藥性和抗微生物管理、新興感染、傳染病的預防與控制，以及疫情應對。
馬克·索耶醫生（MD, FAAP）是2021年紅皮書的副編輯，並於2013年至2019年期間擔任傳染病委員會成員。索耶醫生是拉迪兒童醫院的傳染病專家，並在加州大學聖地牙哥分校擔任臨床小兒科教授。此外，索耶醫生是加州大學聖地牙哥分校小兒科系的教育副主任，以及加州大學聖地牙哥分校/拉迪兒童醫院小兒科住院醫師計畫的計畫主任，並擔任加州大學聖地牙哥分校免疫接種合作計畫的醫療主任。他的臨床和研究興趣包括小兒傳染病、醫學教育、訓練，以及與公共衛生合作推動疫苗接種和國家疫苗政策的工作。
